Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group
Esther Redondo,
Irene Rivero-Calle,
Enrique Mascarós,
Daniel Ocaña,
Isabel Jimeno,
Ángel Gil,
José Luis Díaz-Maroto,
Manuel Linares,
María Ángeles Onieva-García,
Fernando González-Romo,
José Yuste,
Federico Martinón-Torres
Affiliations
Esther Redondo
Infectious, Migrant, Vaccines and Preventive Activities Group of SEMERGEN, International Healthcare Center of Ayuntamiento de Madrid, 28006 Madrid, Spain
Irene Rivero-Calle
Translational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain
Enrique Mascarós
Health Department, Hospital la Fe, Primary Care Center Arquitecto Tolsá, 46019 Valencia, Spain
Daniel Ocaña
Primary Care Health Care Center Algeciras, 11204 Algeciras, Spain
Isabel Jimeno
Primary Care Health Center Isla de Oza, Vaccine Responsible of SEMG, 28034 Madrid, Spain
Ángel Gil
CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain
José Luis Díaz-Maroto
Primary Care Health Center Guadalajara, Infectious Diseases Group SEMERGEN, 19161 Guadalajara, Spain
Manuel Linares
Infectious Diseases Group SEMERGEN, Fundación iO, 28006 Madrid, Spain
María Ángeles Onieva-García
Preventive Medicine Department, Hospital Costa del Sol, 29603 Marbella, Spain
Fernando González-Romo
Clinical Microbiology Department, Health Research Institute (IdISSC), Hospital Clínico San Carlos, School of Medicine, Complutense University of Madrid (UCM), 28040 Madrid, Spain
José Yuste
CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain
Federico Martinón-Torres
Translational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain
In the adult population, community-acquired pneumonia (CAP) is a serious disease that is responsible for high morbidity and mortality rates, being frequently associated with multidrug resistant pathogens. The aim of this review is to update a practical immunization prevention guideline for CAP in Spain caused by prevalent respiratory pathogens, based on the available scientific evidence through extensive bibliographic review and expert opinion. The emergence of COVID-19 as an additional etiological cause of CAP, together with the rapid changes in the availability of vaccines and recommendations against SARS-CoV-2, justifies the need for an update. In addition, new conjugate vaccines of broader spectrum against pneumococcus, existing vaccines targeting influenza and pertussis or upcoming vaccines against respiratory syncytial virus (RSV) will be very useful prophylactic tools to diminish the burden of CAP and all of its derived complications. In this manuscript, we provide practical recommendations for adult vaccination against the pathogens mentioned above, including their contribution against antibiotic resistance. This guide is intended for the individual perspective of protection and not for vaccination policies, as we do not pretend to interfere with the official recommendations of any country. The use of vaccines is a realistic approach to fight these infections and ameliorate the impact of antimicrobial resistance. All of the recently available scientific evidence included in this review gives support to the indications established in this practical guide to reinforce the dissemination and implementation of these recommendations in routine clinical practice.
